FOXO1 and cancer: The discovery of a novel function of FOXO1 in HDACIs-mediated autophagy in human cancer cells may support the development of a novel combinatorial anticancer therapeutic strategies leveraging on a potential synergy between HDACIs and inhibitors of SESNs.